CSIMarket
 
Eton Pharmaceuticals Inc   (NASDAQ: ETON)
 

Eton Pharmaceuticals Inc's Customers Performance

ETON



 
ETON's Source of Revenues During the corresponding time, Eton Pharmaceuticals Inc recorded a revenue increase by 98.63 % year on year, sequentially revenue grew by 58.37 %. While revenue at the Eton Pharmaceuticals Inc 's corporate clients

List of ETON Customers




for the same period Eton Pharmaceuticals Inc recorded revenue increase by 98.63 % year on year, sequentially revenue grew by 58.37 %.

List of ETON Customers

Eton Pharmaceuticals Inc's Business Units
Product    164.56 % of total Revenue






Eton Pharmaceuticals Inc's Comment on Sales, Marketing and Customers



The company develops, manufactures, and delivers pharmaceutical products for patients with rare diseases. Its market strategy includes advancing research and development capabilities and pursuing development through acquisitions, joint ventures, partnerships, and product licensing to expedite product availability. Manufacturing is conducted primarily by third-party contract organizations located in the United States or Europe, adhering to FDA regulations and Good Manufacturing Practices. The company’s product portfolio includes ALKINDI SPRINKLE®, KHINDIVI TM, and ET-600, all protected by patents. Operations are subject to extensive regulation by the FDA and comparable agencies.





Eton Pharmaceuticals Inc’s Comment on Sales, Marketing and Customers


The company develops, manufactures, and delivers pharmaceutical products for patients with rare diseases. Its market strategy includes advancing research and development capabilities and pursuing development through acquisitions, joint ventures, partnerships, and product licensing to expedite product availability. Manufacturing is conducted primarily by third-party contract organizations located in the United States or Europe, adhering to FDA regulations and Good Manufacturing Practices. The company’s product portfolio includes ALKINDI SPRINKLE®, KHINDIVI TM, and ET-600, all protected by patents. Operations are subject to extensive regulation by the FDA and comparable agencies.








ETON's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Eton Pharmaceuticals Inc 1,847.55 86.61 -1.48 44
SUBTOTAL 0.00 0.00 0.00 -

Sources: Eton Pharmaceuticals Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Eton Pharmaceuticals Inc’s corporate clients.
For your research, we’ve provided 9 tables on Eton Pharmaceuticals Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.